Johnson & Johnson buys Firefly Bio for $1B to expand oncology work

July 29, 2026 5:42 PM

Johnson & Johnson (NYSE: JNJ) has completed its acquisition of Firefly Bio, Inc., a biotechnology company, for $1 billion in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found